Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Biotin
Therapeutic Area : Dermatology
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Vestige Marketing Launches Two Innovative Products
Details : Vestige Prime Absorvit (biotin) is a water-soluble B vitamin that plays a crucial role in various metabolic processes in the body. It is indicated for hair loss.
Product Name : Vestige Prime Absorvit
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
September 10, 2024
Lead Product(s) : Biotin
Therapeutic Area : Dermatology
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Biotin,Keratin
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Approved FDF
Sponsor : Dr. Reddy's Laboratories
Deal Size : Undisclosed
Deal Type : Agreement
Nestlé India and Dr. Reddy’s Form Joint Venture for Nutraceutical Portfolio
Details : The two companies will establish a joint venture (JV Company) to introduce innovative nutraceutical brands to consumers, with Nestlé licensing brands like Nature's Bounty, an approved nutritional supplement.
Product Name : Nature’s Bounty
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
April 25, 2024
Lead Product(s) : Biotin,Keratin
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Approved FDF
Sponsor : Dr. Reddy's Laboratories
Deal Size : Undisclosed
Deal Type : Agreement
MedDay Reports Top-Line Data from Phase III Trial “SPI2”
Details : SPI2 was designed to confirm the results of the first positive Phase III study, MS-SPI, in progressive multiple sclerosis (MS).
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
October 03, 2020